Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo (Q37543923)
Jump to navigation
Jump to search
scientific article published on 08 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo |
scientific article published on 08 October 2011 |
Statements
1 reference
Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo (English)
1 reference
Stephanie M Cohen
1 reference
Ridhwi Mukerji
1 reference
Shuang Cai
1 reference
Ivan Damjanov
1 reference
M Laird Forrest
1 reference
Mark S Cohen
1 reference
8 October 2011
1 reference
1 reference
646-52; discussion 652-3
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference